Advocacy

The Government and Public Advocacy Committee (GPAC) met in 2020 to create its action plan. The resulting plan enables the Society to consistently convey the benefits of genetics and genomics research to policymakers and other influencers, and conveys the need for policies supportive of research and the appropriate use of genetics and genomics knowledge. The... Read More

ASHG supports the nomination of Eric Lander, PhD, to lead the Office of Science and Technology Policy (OSTP).  The announcement of the new team at the dawn of President Biden’s presidency, and elevating the Director of OSTP to a Cabinet position, is a positive sign that science, and scientists, will have a core role in... Read More

The first few weeks of 2021 have brought numerous changes to the federal policy landscape, including the beginning of the new Biden Administration, a new Congress with a Democratic majority in both the Senate and the House of Representatives, and the deadly January 6 attack on the U.S. Capitol and its fallout.  While these events... Read More

Federal laws and policies have a major influence on genetics and genomics research and translation to advances in the clinic and the broader society. It is therefore imperative for ASHG to have a strong voice in how such laws and policies are developed and implemented. Recognizing this, the Society’s public policy and advocacy agenda has... Read More

Each year, Congress is tasked with setting budgets across the federal government, including for the National Institutes of Health (NIH), before October 1, the beginning of the new fiscal year. However, this month we passed the October 1 deadline without Congress passing legislation to accomplish this for Fiscal Year 2021. This means that the size... Read More